Submitted by Anonymous (not verified) on 19 March 2026 - 15:26
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 4, Status: Authorised